Reagents and consumables
Ended Awarded Last action
- Contract number
- 75N91024F00004
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $201,338
Award facts
- Contract value 100% obligated
- $201,338.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a delivery order valued at $201,338.13 to Illumina, Inc. for reagents and consumables, with a firm fixed price structure and an ultimate completion date of December 14, 2023. The award was issued without set-aside designation to the San Diego-based biotechnology company, which specializes in genetic sequencing and genomic analysis technologies. Performance will take place in San Diego, California. This delivery order represents a continuation of Illumina's role as a critical supplier of sequencing-related materials and supplies supporting the National Cancer Institute's research and diagnostic initiatives.
Illumina maintains an extensive federal contracting presence across multiple civilian agencies, including a significant $45 million Indefinite Delivery/Indefinite Quantity contract with the U.S. Department of Agriculture through June 2030. The company's federal portfolio encompasses DNA and RNA sequencing instruments, reagent kits, library preparation materials, maintenance services, and bioinformatics software used across infectious disease research, cancer diagnostics, and genomic analysis programs. Most awards to Illumina are structured as firm fixed-price delivery orders and purchase orders reflecting the company's specialized technological position as a primary source for proprietary sequencing systems and associated consumables within the federal research community.
Quick answers
Who was awarded contract 75N91024F00004?
75N91024F00004 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on November 15, 2023.
How much is contract 75N91024F00004 worth?
The government has obligated $201,338 on 75N91024F00004.
Is contract 75N91024F00004 an order under another contract?
Yes. 75N91024F00004 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N91024F00004 competed?
The extent of competition for 75N91024F00004 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award